Growth Opportunity High revenue signals in fertility and women health markets indicate expanding demand; target healthcare providers and clinics within the Cooper Surgical ecosystem and its partners for enhanced sales of IVF and obstetrics-related devices and consumables.

European Expansion Direct sales launch for Labor and Delivery in key European markets suggests a push toward regionalized distribution; leverage this by offering localized support, compliance, and value-added services to accelerate market penetration.

Sustainability Synergy Partnerships focused on recycling plastics from IVF labs indicate openness to sustainability collaborations; present end-to-end equipment lifecycle and recycling program offerings as differentiators to institutions prioritizing ESG.

Product Portfolio Recent product developments such as single-hand inserters for IUDs and acquisitions of surgical device firms signal a broadening portfolio; pursue cross-sell and upsell opportunities across obstetrics, gynecology, and surgical categories.

Risk Mitigation Past litigation over embryo culture quality highlights a need for robust quality assurance and regulatory compliance solutions; position testing, validation, and supplier risk management services to clinics seeking reliability and accreditation support.